I hope people don't have more invested here than they can afford to lose.  Bio stated 60% of his biotech portfolio was in CLSN.  His biotech portfolio only comprises 15% of his total investments so he currently only has 9% of his portfolio in CLSN.  For someone claiming that CLSN is going to $40, that doesn't quite add up.